Research Article

Effect of Thunbergia laurifolia Herbal Tea on Glucose Homeostasis in Healthy Volunteers: A Single-Arm Phase I Study

Table 1

Glucose homeostasis and metabolic profiles at baseline and at 2 weeks.

All (n = 20)TL 9 gm/day (n = 10)TL 12 gm/day (n = 10)
Baseline2 weeks valueBaseline2 weeks valueBaseline2 weeks value

Weight (kg)72.1 ± 16.372.2 ± 16.20.7173.0 ± 17.472.8 ± 17.10.6071.3 ± 16.171.6 ± 16.30.17
BMI (kg/m2)27.5 ± 5.827.6 ± 5.80.6328.1 ± 6.028.0 ± 5.90.6827.0 ± 6.027.1 ± 6.00.17
SBP (mmHg)110 ± 14108 ± 110.52107 ± 13107 ± 100.96116 ± 14110 ± 120.30
DBP (mmHg)66 ± 1067 ± 100.7765 ± 868 ± 110.4867 ± 1266 ± 90.58
FPG (mg/dL)89 ± 689 ± 70.8090 ± 589 ± 60.3688 ± 690 ± 80.24
Fructosamine (μmol/L)213 ± 32212 ± 330.94194 ± 29194 ± 240.93231 ± 25231 ± 320.99
Fasting insulin (μU/mL)8.8 (5.9–18.4)10.4 (7.4–15.2)0.7210.5 (5.9–22.9)11.7 (7.9–15.3)0.797.9 (5.8–17.0)9.5 (6.5–15.6)1.00
HOMA-B101.6 (82.3–189.8)120.4 (93.2–153.2)0.77113.4 (81.0–201.4)130.2 (97.3–161.3)0.4596.2 (83.7–184.5)104.1 (85.8–137.4)0.51
HOMA-S88.2 (43.6 130.3)73.8 (50.7–107.0)0.3173.4 (34.9–130.4)68.5 (51.7–97.8)0.2495.6 (47.1–132.3)81.2 (49.4–120.3)0.96
HOMA-IR1.14 (0.77–2.31)1.37 (0.94–1.98)0.651.37 (0.77–2.87)1.50 (1.03–1.94)0.721.05 (0.76–2.14)1.27 (0.84–2.03)0.88
Cholesterol (mg/dL)195 ± 28200 ± 290.25198 ± 24201 ± 340.67192 ± 32199 ± 250.67
TG (mg/dL)91 ± 2897 ± 380.2496 ± 32104 ± 450.2986 ± 2591 ± 300.29
HDL-C (mg/dL)52 ± 953 ± 110.3549 ± 850 ± 110.4254 ± 955 ± 100.42
Cal-LDL-C (mg/dL)125 ± 28128 ± 270.50130 ± 26130 ± 310.96121 ± 31126 ± 250.96
hs-CRP (mg/L)1.49 (0.72–2.63)1.31 (0.58–3.20)0.771.43 (0.71–2.44)1.26 (0.78–3.31)0.261.73 (0.61–3.87)1.58 (0.44–3.78)0.14

Data presented as mean ± standard deviation or median and interquartile range. A value <0.05 indicates statistical significance. Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HOMA-B, homeostatic model assessment of β-cell function; HOMA-S, homeostatic model assessment of insulin sensitivity; HOMA-IR, homeostatic model assessment of insulin resistance; HDL, high-density lipoprotein cholesterol; cal-LDL-C, calculated low-density lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein.